Flibanserin-d4-1
Modify Date: 2024-01-10 09:51:41
Flibanserin-d4-1 structure
|
Common Name | Flibanserin-d4-1 | ||
|---|---|---|---|---|
| CAS Number | 2122830-91-3 | Molecular Weight | 394.43 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H17D4F3N4O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Flibanserin-d4-1Flibanserin-d4-1 is deuterium labeled Flibanserin. Flibanserin (BIMT-17) is a full agonist of the serotonin 5-HT1A receptor (Ki=1 nM) and an antagonist of 5-HT2A (49 nM). Flibanserin binds to dopamine D4 receptors (4-24 nM), and has negligible affinity for a variety of other neurotransmitter receptors and ion channels. Flibanserin is efficacious in treating hypoactive sexual desire disorder (HSDD)[1][2]. |
| Name | Flibanserin-d4-1 |
|---|
| Description | Flibanserin-d4-1 is deuterium labeled Flibanserin. Flibanserin (BIMT-17) is a full agonist of the serotonin 5-HT1A receptor (Ki=1 nM) and an antagonist of 5-HT2A (49 nM). Flibanserin binds to dopamine D4 receptors (4-24 nM), and has negligible affinity for a variety of other neurotransmitter receptors and ion channels. Flibanserin is efficacious in treating hypoactive sexual desire disorder (HSDD)[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C20H17D4F3N4O |
|---|---|
| Molecular Weight | 394.43 |